Identification of the CYP19A1-GPER1 axis as a critical oncogenic driver in hepatocellular carcinoma via AKT activation - PubMed
3 hours ago
- #CYP19A1-GPER1 Axis
- #Hepatocellular Carcinoma
- #AKT Activation
- CYP19A1 overexpression correlates with advanced HCC stages and poor survival.
- The CYP19A1-GPER1 axis drives HCC progression via AKT activation, affecting proliferation and metastasis.
- Targeting the CYP19A1-GPER1 axis could be a promising therapeutic strategy for hepatocellular carcinoma.